These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 14745718)
21. Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma. Puglisi F; Barbone F; Damante G; Bruckbauer M; Di Lauro V; Beltrami CA; Di Loreto C Mod Pathol; 1999 Mar; 12(3):318-24. PubMed ID: 10102618 [TBL] [Abstract][Full Text] [Related]
22. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment. Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463 [TBL] [Abstract][Full Text] [Related]
23. [Expression and clinical significance of the thyroid transcription factor 1 in Xuanwei lung adenocarcinoma]. Zu Y; Wang X; Liu X; Chen Y; Li C; Shang X; Xie Y; Zhao H; Wang J Zhongguo Fei Ai Za Zhi; 2013 Mar; 16(3):131-7. PubMed ID: 23514941 [TBL] [Abstract][Full Text] [Related]
24. Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma. Kadota K; Nitadori J; Sarkaria IS; Sima CS; Jia X; Yoshizawa A; Rusch VW; Travis WD; Adusumilli PS Cancer; 2013 Mar; 119(5):931-8. PubMed ID: 23096929 [TBL] [Abstract][Full Text] [Related]
25. Observations on bronchiolo-alveolar carcinomas with special emphasis on localized lesions. A clinicopathological, ultrastructural, and immunohistochemical study of 11 cases. Axiotis CA; Jennings TA Am J Surg Pathol; 1988 Dec; 12(12):918-31. PubMed ID: 2849325 [TBL] [Abstract][Full Text] [Related]
26. Patterns of recurrence of bronchioloalveolar cell carcinoma after surgical resection: a radiological, histological, and immunohistochemical study. Gaeta M; Blandino A; Pergolizzi S; Mazziotti S; Caruso R; Barone M; Cascinu S Lung Cancer; 2003 Dec; 42(3):319-26. PubMed ID: 14644520 [TBL] [Abstract][Full Text] [Related]
27. Expression and significance of cyclin D1, p27kip1 protein in bronchioloalveolar carcinoma. Yuan JQ; Xu JY; Zhang J; He QC; Zhu J; Sheng CX J Zhejiang Univ Sci; 2004 Feb; 5(2):235-41. PubMed ID: 14674039 [TBL] [Abstract][Full Text] [Related]
28. Morphologic and immunocytochemical studies of bronchioloalveolar carcinoma at Duke University Medical Center, 1968-1986. Elson CE; Moore SP; Johnston WW Anal Quant Cytol Histol; 1989 Aug; 11(4):261-74. PubMed ID: 2548519 [TBL] [Abstract][Full Text] [Related]
29. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins. Myong NH J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324 [TBL] [Abstract][Full Text] [Related]
30. The expression of TTF-1 and Napsin A in early-stage lung adenocarcinoma correlates with the results of surgical treatment. Ma Y; Fan M; Dai L; Kang X; Liu Y; Sun Y; Yan W; Liang Z; Xiong H; Chen K Tumour Biol; 2015 Sep; 36(10):8085-92. PubMed ID: 25982999 [TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas. Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636 [TBL] [Abstract][Full Text] [Related]
32. Epidermal growth factor receptor signaling in adenocarcinomas with bronchioloalveolar components. Sarkaria IS; Zakowski MF; Pham D; Hezel M; Ebright MI; Chuai S; Venkatraman ES; Kris MG; Rusch VW; Singh B Ann Thorac Surg; 2008 Jan; 85(1):216-23. PubMed ID: 18154814 [TBL] [Abstract][Full Text] [Related]
33. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Jones TD; Kernek KM; Yang XJ; Lopez-Beltran A; MacLennan GT; Eble JN; Lin H; Pan CX; Tretiakova M; Baldridge LA; Cheng L Hum Pathol; 2005 Jul; 36(7):718-23. PubMed ID: 16084939 [TBL] [Abstract][Full Text] [Related]
34. SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma. Sarkaria IS; Pham D; Ghossein RA; Talbot SG; Hezel M; Dudas ME; Ebright MI; Chuai S; Memoli N; Venkatraman ES; Miller VA; Kris MG; Zakowski MF; Rusch VW; Singh B Ann Thorac Surg; 2004 Nov; 78(5):1734-41. PubMed ID: 15511464 [TBL] [Abstract][Full Text] [Related]
36. Thyroid transcription factor-1 as a prognostic indicator for stage IV lung adenocarcinoma with and without EGFR-sensitizing mutations. Park JY; Jang SH; Kim HI; Kim JH; Park S; Hwang YI; Jung KS; Seo J; Lee CY; Ko Y; Park YB BMC Cancer; 2019 Jun; 19(1):574. PubMed ID: 31196060 [TBL] [Abstract][Full Text] [Related]
37. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloalveolar carcinoma. Ebright MI; Zakowski MF; Martin J; Venkatraman ES; Miller VA; Bains MS; Downey RJ; Korst RJ; Kris MG; Rusch VW Ann Thorac Surg; 2002 Nov; 74(5):1640-6; discussion 1646-7. PubMed ID: 12440623 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270 [TBL] [Abstract][Full Text] [Related]